Pharmacogenomic test that predicts response to ß2-agonists in adults with asthma is cost effective.
Wu AC, Gay C, Rett MD, Fuhlbrigge AL. Pharmacogenomic test that predicts response to ß2-agonists in adults with asthma is cost effective. Per Med. 2015 Nov; 12(6):574-584.